Attached files
| file | filename |
|---|---|
| EX-4.2 - DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT OF 193 - Protara Therapeutics, Inc. | f10k2020ex4-2_protara.htm |
| EX-10.25 - LEASE BY AND BETWEEN 345 PAS HOLDING LLC, AND THE REGISTRANT, DATED AS OF DECEMB - Protara Therapeutics, Inc. | f10k2020ex10-25_protara.htm |
| EX-23.1 - CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Protara Therapeutics, Inc. | f10k2020ex23-1_protara.htm |
| EX-31.1 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex31-1_protara.htm |
| EX-32.1 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex32-1_protara.htm |
| EX-31.2 - CERTIFICATION - Protara Therapeutics, Inc. | f10k2020ex31-2_protara.htm |
| 10-K - ANNUAL REPORT - Protara Therapeutics, Inc. | f10k2020_protaratherapeutics.htm |
Exhibit 21.1
List of Subsidiaries
| Name of Subsidiary | Jurisdiction | |
| Proteon Securities Corp. | Massachusetts | |
| Proteon International Holdings, Inc. | Delaware | |
| Proteon Bermuda Limited | Bermuda | |
| Proteon Ireland Limited | Ireland | |
| ArTara Subsidiary, Inc. | Delaware |
All subsidiaries are 100% owned.